The license covering Novogen patent rights to soy isoflavones, which was with the DuPont joint venture company Solae LLC, has now been transferred to Archer Daniels Midland company (ADM).
ADM has assumed the rights and obligations formerly held by Solae, including royalty and milestone payments under the Novogen license.